A/(H3N2)-Like Virus Antigen, B (Yamagata Lineage)-Like Virus Antigen, B (Victoria Lineage)-Like Virus Antigen, A/H1N1 Influenza Vaccine

1 trials JAnti-infectives

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

3 Countries

Phase III

Phase III: 1

Indications tested

Sponsors using this IMP

Seqirus UK Limited 1

All trials

1 total

The Celljuvant study, A phase 3 Immunogenicity and Safety Study of aQIVc HD Vaccine in Adults aged 50 years and older. Ended

2023-503763-42-00 Phase III 3 countries Seqirus UK Limited

Showing 1–1 of 1 trials

← All drugs A–Z